Helicobacter pylori: Review of Clinical and Public Health Aspects for the Practitioner

Infectious Diseases in Clinical Practice

Volumn 8, Issue 3, 1999, Pages 137-145

  Dworkin, Mark S ^a   Gold, Benjamin D ^b,c   Swerdlow, David L ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; DISEASE TRANSMISSION; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; VACCINATION;

EID: 0032964240     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/00019048-199903000-00010     Document Type: Article

References (107)

1. Sonnenberg A. Peptic ulcer. In: Everhart JE, editor. Digestive diseases in the United States: epidemiology and impact [NIH publication no. 94-1447]. Washington (DC): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1994. p. 359-408.
2. Steer HW. Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. J Clin Pathol 1975;28: 39-46.
3. Marshall BJ, Royce H, Annear DI, et al. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett 1984;25:83-8.
4. Monmaney T. Marshall's hunch. The New Yorker 1993 Sep20;64-72.
5. Cover TL, Blaser MJ. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News 1995;61:21-6.
6. Penner JL. Campylobacter, Helicobacter, and related spiral bacteria. In: Balows A, editor. Manual of clinical microbiology. Washington (DC): American Society for Microbiology; 1991. p. 402-9.
7. Lee A, O'Rourke J. Gastric bacteria other than Helicobacter pylori. Gastroenterol Clin North Am 1993;22:21-42.
8. Burnens AP, Stanley J, Morgenstern R, et al. Gastroenteritis associated with Helicobacter pullorum. Lancet 1994;344:1569-70.
9. Fox JG, Li X, Yan L, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of He/icobacfer-induced carcinogenesis. Infect Immun 1996;64:1548-58.
10. Ramsey EJ, Carey K, Peterson WL, et al. Epidemic gastritis with hypochlorhydria. Gastroenterology 1979;76:1449-57.
11. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272: 65-9.
12. Wyatt JI, Rathbone BJ, Dixon MF, et al. Campylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987;40:841-8.
13. Alper J. Ulcers as an infectious disease. Science 1993;260:159-60.
14. Cotton P. NIH consensus panel urges antimicrobials for ulcer patients, skeptics concur with caveats. JAMA 1994;271:808-9.
15. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. J Clin Gastroenterol 1997;24:2-17.
16. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 Suppl 8:S116-28.
17. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:143 7-42.
18. Schubert TT, Bologna SD, Nensey Y. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 1993;94:413-8.
19. Nomura A, Stemmermann GN, Chyou P, et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
20. Peterson WL. Helicobacter pylori and peptic ulcer disease. N EnglJ Med 1991;324:1043-8.
21. Fennerty MB. Helicobacter pylori. Arch Intern Med 1994;154:721-7.
22. Holtmann G, Goebell H, Holtmann M, et al. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994;39:1090-8.
23. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol Suppl 1996; 220:19-22.
24. Parsonnet J. Helicobacter pylori. Emerg Infect Dis 1998;12:185-97.
25. Tiomny E, Arber N, Moshkowitz M, et al. Halitosis and Helicobacter pylori: a possible link? J Clin Gastroenterol 1992;15:236-7.
26. Sung JJ, Sanderson JE. Hyperhomocys-teinaemia, Helicobacter pylori and coronary artery disease. Heart 1996;76:305-7.
27. Weston AP, Cherian R, Horvat RT, et al. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma and Helicobacter pylori. Am J Gastroenterol 1997;92:800-4.
28. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
29. The EUROGAST study group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341: 1359-62.
30. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
31. Wotherspoon AC, Daglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
32. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
33. Stolte M, Eidt S. Healing gastric MALT lymphomas by eradicating H. pylori [comment]? Lancet 1993;342:568.
34. Hussell T, Isaacson PC, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342:571-4.
35. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:73-88.
36. Clemens J, Albert MJ, Rao M, et al. Sociodemographics, hygienic and nutritional correlates of Helicobacter pylori infection of young Bangladeshi children. Pediatr Infect Dis J 1996;15:1113-8.
37. Staat MA, Kruszon-Moran D, McQuillan GM, et al. A population based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J infect Dis 1996;174:1120-3.
38. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102:760-6.
39. Perez-Perez GI, Dworkin BM, Chodos JE, et al. Campylobacter pylori antibodies in humans. Ann Intern Med 1988;109:11-7.
40. Thomas JE, Gibson GR, Darboe MK, et al. Isolation of Helicobacter pylori from human faeces. Lancet 1992;340:1194-5.
41. Mitchell HM, Lee A, Carrick J. Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol 1989;24:396-400.
42. Reiff A, Jacobs E, Kist M. Seroepidemiological study of immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis 1989;8:592-6.
43. Malaty HM, Evans DJ, Abromovitch K, et al. Helicobacter pylori infection in dental workers: a seroepidemiologic study. Am J Gastroenterol 1992;87:1728-31.
44. Wilhoite SL, Ferguson DA, Soike DR, et al. Increased prevalence of Helicobacter pylori antibodies among nurses. Arch Intern Med 1993;153:708-12.
45. Hammermeister I, Janus G, Schamarowski F, et al. Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis 1992;11:9-14.
46. Perez-Perez GI, Taylor DN, Bodhidatta L, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990;161: 1237-41.
47. Klein PD, Gastrointestinal Physiology Working Group, Graham DY, et al. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991;337:1503-6.
48. Hülfen K, Han SW, Enroth H, et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996; 110:1031-5.
49. Bateson MC. Cigarette smoking and Helicobacter pylori infection. Postgrad Med J 1993;69:41-4.
50. Borody TJ. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. Am J Gastroenterol 1992;87: 1390-3.
51. Hook-Nikanne J. Effect of alcohol consumption on the risk of Helicobacter pylori infection. Digestion 1991;50:92-8.
52. Gangaidzo I, Kiire C, Mason P, et al. Prospective endoscopic study of duodenal ulcer in Zimbabwean blacks. Cent Afr J Med 1992;38: 397-402.
53. Ruoff M. Helicobacterpyloriandthestomach. Mediguide Infect Dis 1993;13:1-4.
54. Neumann JK, Rohrbach MA, Wilholte S, et al. Helicobacter pylori and pathogenesis of ulceration [letter]. Lancet 1993;341:702-3.
55. Ernst PB, Gold BD. Helicobacter pylori in childhood: new insights in the pathogenesis of gastric disease and implications for managing infection in children. J Pediatr Gastroenterol Nutr, in press.
56. Whitney AE, Guarner J, L Hutwagner, et al. Histopathological differences between Helicobacter pylori gastritis of children and adults. Gastroenterology 1998; 114:A331.
57. Wyatt JL Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori. Histopathology 1995;26:1-15.
58. Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996;10 Suppl 1:79-96.
59. Mobley HLT, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995;59:1992-4.
60. Matsui T, Matsukawa Y, Sakai T, et al. Effect of ammonia on cell-cycle progression of human gastric cancer cells. Eur J Gastroenterol Hepatol 1995;7 Suppl 1:S79-81.
61. Slomiany BL, Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol 1992; 14 Suppl 1: S114-S121.
62. Salmela KS, Roine RP, Koivisto T, et al. Characteristics of Helicobacter pylori alcohol dehydrogenase. Gastroenterology 1993;105: 325-30.
63. Langenberg WE, Rauws EAJ, Widjojokusomo A, et al. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986;24: 414-7.
64. Blaser MJ. Hypotheses on pathogenesis and natural history of Helicobacter pylori- induced inflammation. Gastroenterology 1992;102: 720-7.
65. Kanamori Y, Ishimuru K, Nanno M, etal. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+IL-7R+Thy1 + lymphohematopoietic progenitors develop. J Exp Med 1996;184:1449-59.
66. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
67. Blaser MJ. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987;93:371-83.
68. Chan EX, Chen KT, Lin YL. Vacuolating toxin from Helicobacter pylori activates cellular signaling and pepsinogen secretion in human gastric adenocarcinoma cells. FEBS Lett 1996; 399:127-30.
69. Moss S, Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut 1992;33: 289-92.
70. Mulholland G, Ardill JE, Fillmore D, et al. Helicobacter pylori related hypergastrinemia Is the result of selective increase in gastrin 17. Gut 1993;34:757-61.
71. Buchan AM, Meloch RM, Kwok YN, et al. Effect of cholecystokinin and secretin on somatostatin release from cultured antral cells. Gastroenterology 1993; 104:1414-9.
72. Prinz C, Neumayer N, Mahr S, et al. Functional impairment of rat enterochromaffin-like cells by interleukin 1 b. Gastroenterology 1997;112:364-75.
73. Olbe L, Hamlet A, Dalenbeck J, et al. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996; 110: 1386-94.
74. Karnes WE, Ohning GV, Sytnik B, et al. Preservation of pH inhibition of gastrin release in subjects with Helicobacter pylori. Rev Infect Dis 1991;13:S665-70.
75. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 Suppl 1:43-53.
76. Megraud F. How should Helicobacter pylori infection be diagnosed? Gastroenterology 1997;113 Suppl 6:S93-S98.
77. Kasper G, Dickgiesser N. Isolation from gastric epithelium of Campylobacter-\ike bacteria that are distinct from "Campylobacter pylorldis." Lancet 1985;1:111-2.
78. Brown KE, Peura DA. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:105-15.
79. Giupczynski Y. The diagnosis of Helicobacter pylori infection: a microbiologist's perspective. Rev Med Microbiol 1994;5:199-208.
80. Goodwin S. Detection of H. pylori infection by biopsy urease, histology and culture. In: Clayton CL, Mobley HLT, editors. Helicobacter pylori protocols. Methods in molecular medicine. Totowa (NJ): Humana Press; 1997. p. 2-7.
81. Barthel JS, Everett ED. Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives. Rev Infect Dis 1990;12 Suppl 1:S107-14.
82. 4Curea breath test as a semi-quantitative monitoring instrument after therapy for Helicobacter pylori infection. Scand J Gastroenterol 1997;32:112-7.
83. 13C urea breath test. Am J Gastroenterol 1996;91:690-4.
84. Westblom TU, Phadnis S, Yang P, et al. Diagnosis of Helicobacter pylori infection by means of a polymerase chain reaction assay for gastric juice aspirate. Clin Infect Dis 1993;16:367-71.
85. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low grade gastric lymphoma of mucosa associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
86. van der Hulst RW, Keller JJ, Rauws EA, et al. Treatment of Helicobacter pylori infection in humans: a review of the world literature. Helicobacter 1996;1:6-19.
87. Hawkey CJ. Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. BMJ 1994;309:1570-1.
88. Record CO. Helicobacter pylori is not the causative agent. BMJ 1994;309:1571-2.
89. Graham DY, Klein PD, Opekun AR, et al. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol 1989;84:233-8.
90. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am j Gastroenterol 1993;88: 505-9.
91. Goodwin CS, Marshall BJ, Blincow ED, et al. Prevention of nitroimidazole resistance In Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988;41:207-10.
92. Giupczynski Y, Labbe M, Burette A, et al. Treatment failure of ofloxacin in Campylobacter pylori infection [letter]. Lancet 1987;1: 1096.
93. Stone JW, Wise R, Donovan IA, et al. Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J Antimicrob Chemother 1988;22:92-3.
94. Marshall BJ. Treatment strategies for Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:183-98.
95. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre survey In. 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol 1992;11:777-81.
96. Centers for Disease Control and Prevention. Knowledge about causes of peptic ulcer disease-United States, March-April, 1997. MMWR 1997;46:985-7.
97. Jaskiewicz K, Louw JA, Marks IN. Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori. Dig Dis Sci 1993;38:937-43.
98. Wyatt Jl, Rathbone BJ. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988;23 Suppl 142:44-9.
99. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993;11:637-42.
100. Chen MH, Lee A, Hazell S, et al. Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer? Int J Microbiol Virol Parasitol Infect Dis 1993;280:155-65.
101. Rappuoli R, Covacci A, Ghiara P, et al. Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen. Behring Inst Mitt 1994;95:42-8.
102. Negrini R, Coiesi C, Savio A, et al. Molecular mimicry of gastric antigens by Helicobacter pylori: a role in the pathogenesis of atrophic gastritis [letter]. Am J Gastroenterol 1994;89:1329.
103. Corthesy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter pylori infection in mice. Gastroenterology 1995;109:115-21.
104. Doidge C, Gust I, Lee A, et al. Therapeutic immunization against Helicobacter pylori infection [letter]. Lancet 1994;343:914-5.
105. Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91:1544-8.
106. Breuer T, Malaty HM, Goodman K, et al. Has the scientific evidence about Helicobacter pylori infection in gastrointestinal diseases reached the practicing physicians in the United States? Am J Gastroenterol 1996;91:1905.
107. el-Omar E, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113:15-24.